Nymox Pharmaceutical
NYMX
#10186
Rank
NZ$31.41 M
Marketcap
Country
NZ$0.34
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

EPS for Nymox Pharmaceutical (NYMX)

EPS in 2023 (TTM): NZ-$0.09947

According to Nymox Pharmaceutical's latest financial reports the company's current EPS (TTM) is NZ-$0.10. In 2022 the company made an earnings per share (EPS) of NZ-$0.14 an increase over its 2021 EPS that were of NZ-$0.26.

EPS history for Nymox Pharmaceutical from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ-$0.09947-27.76%
2022NZ-$0.14-46.67%
2021NZ-$0.26-11.76%
2020NZ-$0.29-15%
2019NZ-$0.345.26%
2018NZ-$0.33-26.92%
2017NZ-$0.45-7.14%
2016NZ-$0.48-40.43%
2015NZ-$0.81291.67%
2014NZ-$0.21-7.69%
2013NZ-$0.22-43.48%
2012NZ-$0.40-25.81%
2011NZ-$0.5355%
2010NZ-$0.3425%
2009NZ-$0.280.08%
2008NZ-$0.28-11.12%
2007NZ-$0.31-0.16%
2006NZ-$0.3128.59%
2005NZ-$0.24-12.49%
2004NZ-$0.28-16.05%
2003NZ-$0.3319.07%
2002NZ-$0.2814.45%
2001NZ-$0.24-22.16%
2000NZ-$0.315.64%
1999NZ-$0.29-34.59%
1998NZ-$0.45-3.6%
1997NZ-$0.46

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Abbott Laboratories
ABT
NZ$13.87-13,528.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.96-2,966.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$14.87-14,500.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$35.32-34,297.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$17.97-17,499.00%๐Ÿ‡บ๐Ÿ‡ธ USA